Subtopic Deep Dive
Antibiotic-Associated Diarrhea Epidemiology
Research Guide
What is Antibiotic-Associated Diarrhea Epidemiology?
Antibiotic-Associated Diarrhea Epidemiology studies the population-level incidence, risk factors, and transmission dynamics of diarrhea caused by Clostridium difficile following antibiotic exposure.
Researchers analyze surveillance data to track healthcare-associated outbreaks of C. difficile infection (CDI). Key studies identify toxin gene-variant strains and antibiotic-induced microbiome shifts as drivers (McDonald et al., 2005; Theriot et al., 2014). Over 10 high-citation papers from 2005-2020 document rising CDI rates linked to fluoroquinolone resistance and PPI use.
Why It Matters
Epidemiological data from McDonald et al. (2005) revealed a fluoroquinolone-resistant C. difficile strain causing widespread outbreaks, prompting infection control changes in hospitals. Theriot et al. (2014) showed antibiotic-induced microbiome shifts increase CDI susceptibility in mouse models, informing stewardship programs. Imhann et al. (2015) linked PPIs to enteric infections like CDI via microbiome disruption, influencing prescribing guidelines (McDonald et al., 2018). These insights reduce healthcare costs from CDI, affecting millions annually.
Key Research Challenges
Strain Variability Tracking
Epidemic toxin gene-variant strains spread geographically, complicating outbreak surveillance (McDonald et al., 2005). Fluoroquinolone resistance emerges rapidly, requiring real-time genomic epidemiology. Limited longitudinal data hinders prediction models.
Risk Factor Quantification
Antibiotics and PPIs disrupt gut microbiota, elevating CDI risk, but population-attributable fractions remain unclear (Imhann et al., 2015; Theriot et al., 2014). Confounding from comorbidities challenges multivariate analyses. Prospective cohort studies are resource-intensive.
Outbreak Transmission Modeling
Healthcare-associated CDI transmission dynamics involve environmental persistence and patient mobility (McDonald et al., 2018). Surveillance data gaps limit agent-based models. Integration of microbiome and epidemiological data is nascent.
Essential Papers
An Epidemic, Toxin Gene–Variant Strain of <i>Clostridium difficile</i>
L. Clifford McDonald, George Killgore, Angela Thompson et al. · 2005 · New England Journal of Medicine · 2.0K citations
A previously uncommon strain of C. difficile with variations in toxin genes has become more resistant to fluoroquinolones and has emerged as a cause of geographically dispersed outbreaks of C. diff...
Bacterial and Fungal Coinfection in Individuals With Coronavirus: A Rapid Review To Support COVID-19 Antimicrobial Prescribing
Timothy M. Rawson, Luke Moore, Nina Zhu et al. · 2020 · Clinical Infectious Diseases · 1.7K citations
Abstract Background To explore and describe the current literature surrounding bacterial/fungal coinfection in patients with coronavirus infection. Methods MEDLINE, EMBASE, and Web of Science were ...
Proton pump inhibitors affect the gut microbiome
Floris Imhann, Marc Jan Bonder, Arnau Vich Vila et al. · 2015 · Gut · 1.3K citations
Background and aims Proton pump inhibitors (PPIs) are among the top 10 most widely used drugs in the world. PPI use has been associated with an increased risk of enteric infections, most notably Cl...
Clinical Practice Guidelines for Clostridium difficile Infection in Adults and Children: 2017 Update by the Infectious Diseases Society of America (IDSA) and Society for Healthcare Epidemiology of America (SHEA)
L. Clifford McDonald, Dale N. Gerding, Stuart Johnson et al. · 2018 · Clinical Infectious Diseases · 1.1K citations
Abstract A panel of experts was convened by the Infectious Diseases Society of America (IDSA) and Society for Healthcare Epidemiology of America (SHEA) to update the 2010 clinical practice guidelin...
European consensus conference on faecal microbiota transplantation in clinical practice
Giovanni Cammarota, Gianluca Ianiro, Herbert Tilg et al. · 2017 · Gut · 1.1K citations
Faecal microbiota transplantation (FMT) is an important therapeutic option for Clostridium difficile infection. Promising findings suggest that FMT may play a role also in the management of other d...
Antibiotic-induced shifts in the mouse gut microbiome and metabolome increase susceptibility to Clostridium difficile infection
Casey M. Theriot, Mark J. Koenigsknecht, Paul E. Carlson et al. · 2014 · Nature Communications · 961 citations
Intestinal microbiota in functional bowel disorders: a Rome foundation report
Magnus Simrén, Giovanni Barbara, Harry J. Flint et al. · 2012 · Gut · 907 citations
It is increasingly perceived that gut host–microbial interactions are important elements in the pathogenesis of functional gastrointestinal disorders (FGID). The most convincing evidence to date is...
Reading Guide
Foundational Papers
Start with McDonald et al. (2005) for epidemic strain discovery and fluoroquinolone resistance; follow with Theriot et al. (2014) for microbiome mechanisms underlying susceptibility.
Recent Advances
Study McDonald et al. (2018) guidelines for updated epidemiology and control; review Imhann et al. (2015) on PPI microbiome effects.
Core Methods
Core techniques: toxin gene PCR for strain typing (McDonald et al., 2005), 16S rRNA sequencing for microbiota shifts (Theriot et al., 2014; Imhann et al., 2015), prospective surveillance cohorts (McDonald et al., 2018).
How PapersFlow Helps You Research Antibiotic-Associated Diarrhea Epidemiology
Discover & Search
Research Agent uses searchPapers and citationGraph to map CDI epidemiology from McDonald et al. (2005), revealing 1993 citations and outbreak connections. exaSearch finds surveillance studies on antibiotic risks; findSimilarPapers expands to Theriot et al. (2014) mouse models.
Analyze & Verify
Analysis Agent applies readPaperContent to extract incidence rates from McDonald et al. (2018) guidelines, then verifyResponse with CoVe checks claims against 250M+ papers. runPythonAnalysis with pandas models risk ratios from Imhann et al. (2015) PPI data; GRADE grading scores guideline evidence quality.
Synthesize & Write
Synthesis Agent detects gaps in fluoroquinolone resistance epidemiology post-2005, flags contradictions between strain reports. Writing Agent uses latexEditText for incidence tables, latexSyncCitations for 10+ papers, latexCompile for reports, exportMermaid for transmission flowcharts.
Use Cases
"Extract CDI incidence rates from surveillance data in McDonald papers and plot trends with Python."
Research Agent → searchPapers('McDonald CDI epidemiology') → Analysis Agent → readPaperContent + runPythonAnalysis(pandas/matplotlib for time-series plot of 1993-cited 2005 outbreak data) → researcher gets CSV-exported incidence trends.
"Compile LaTeX review on antibiotic risk factors for CDI outbreaks."
Synthesis Agent → gap detection on Theriot/Imhann risks → Writing Agent → latexEditText(draft sections) → latexSyncCitations(10 papers) → latexCompile → researcher gets polished PDF with cited epidemiology tables.
"Find GitHub repos analyzing C. difficile microbiome shift data from Theriot 2014."
Research Agent → citationGraph('Theriot 2014') → Code Discovery → paperExtractUrls → paperFindGithubRepo → githubRepoInspect → researcher gets vetted repos with antibiotic susceptibility scripts.
Automated Workflows
Deep Research workflow conducts systematic review of 50+ CDI papers, chaining searchPapers → citationGraph → GRADE grading for incidence meta-analysis. DeepScan's 7-step analysis verifies risk factors from Imhann et al. (2015) with CoVe checkpoints and Python stats. Theorizer generates hypotheses on PPI-CDI transmission from McDonald et al. (2005/2018).
Frequently Asked Questions
What defines Antibiotic-Associated Diarrhea Epidemiology?
It examines incidence, risk factors, and transmission of C. difficile diarrhea post-antibiotics using surveillance data (McDonald et al., 2005).
What are key methods in this subtopic?
Methods include genomic strain typing, microbiome 16S sequencing, and cohort surveillance for outbreak modeling (Theriot et al., 2014; Imhann et al., 2015).
What are seminal papers?
McDonald et al. (2005, 1993 citations) identified epidemic strains; McDonald et al. (2018, 1115 citations) updated CDI guidelines.
What open problems exist?
Challenges include quantifying PPI-attributable CDI risk and modeling post-antibiotic transmission in diverse populations (Imhann et al., 2015).
Research Clostridium difficile and Clostridium perfringens research with AI
PapersFlow provides specialized AI tools for Medicine researchers. Here are the most relevant for this topic:
Systematic Review
AI-powered evidence synthesis with documented search strategies
AI Literature Review
Automate paper discovery and synthesis across 474M+ papers
Find Disagreement
Discover conflicting findings and counter-evidence
Paper Summarizer
Get structured summaries of any paper in seconds
See how researchers in Health & Medicine use PapersFlow
Field-specific workflows, example queries, and use cases.
Start Researching Antibiotic-Associated Diarrhea Epidemiology with AI
Search 474M+ papers, run AI-powered literature reviews, and write with integrated citations — all in one workspace.
See how PapersFlow works for Medicine researchers